Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 4 studies | 31% ± 7% | |
oligodendrocyte | 4 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of TRIM62 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 599.46 | 1445 / 1445 | 100% | 11.50 | 183 / 183 |
prostate | 100% | 901.39 | 245 / 245 | 100% | 14.79 | 502 / 502 |
skin | 100% | 1520.44 | 1809 / 1809 | 100% | 20.93 | 472 / 472 |
brain | 100% | 1004.65 | 2638 / 2642 | 100% | 17.26 | 705 / 705 |
ovary | 100% | 590.79 | 180 / 180 | 100% | 13.18 | 429 / 430 |
thymus | 100% | 696.92 | 652 / 653 | 99% | 7.78 | 601 / 605 |
breast | 100% | 649.99 | 458 / 459 | 99% | 13.93 | 1109 / 1118 |
uterus | 100% | 536.12 | 170 / 170 | 99% | 10.91 | 453 / 459 |
stomach | 100% | 561.45 | 359 / 359 | 98% | 7.18 | 281 / 286 |
bladder | 100% | 732.62 | 21 / 21 | 98% | 11.59 | 495 / 504 |
intestine | 100% | 557.84 | 966 / 966 | 98% | 6.37 | 517 / 527 |
lung | 99% | 526.49 | 573 / 578 | 99% | 8.45 | 1143 / 1155 |
kidney | 100% | 525.87 | 89 / 89 | 95% | 5.23 | 852 / 901 |
adrenal gland | 100% | 1013.02 | 258 / 258 | 94% | 17.76 | 217 / 230 |
pancreas | 93% | 280.54 | 305 / 328 | 99% | 7.40 | 176 / 178 |
liver | 52% | 108.94 | 117 / 226 | 52% | 2.00 | 212 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.38 | 29 / 29 |
spleen | 100% | 834.47 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.04 | 1 / 1 |
blood vessel | 100% | 643.66 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 485.85 | 1199 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 300.97 | 821 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 440.43 | 868 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 4.96 | 74 / 80 |
muscle | 84% | 458.76 | 672 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0045087 | Biological process | innate immune response |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0044314 | Biological process | protein K27-linked ubiquitination |
GO_0010719 | Biological process | negative regulation of epithelial to mesenchymal transition |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_1905036 | Biological process | positive regulation of antifungal innate immune response |
GO_0019076 | Biological process | viral release from host cell |
GO_0046596 | Biological process | regulation of viral entry into host cell |
GO_0032897 | Biological process | negative regulation of viral transcription |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TRIM62 |
Protein name | E3 ubiquitin-protein ligase TRIM62 (EC 2.3.2.27) (Tripartite motif-containing protein 62) |
Synonyms | |
Description | FUNCTION: E3 ubiquitin ligase that plays a role in antifungal immunity by mediating 'Lys-27'-linked ubiquitination of CARD9 downstream of C-type lectin receptors; leading to CARD9 activation, followed by activation of NF-kappa-B and MAP kinase p38 pathways . E3 ubiquitin ligase activity is dependent on E2 ubiquitin-conjugating enzyme UBE2D2 . . |
Accessions | ENST00000291416.10 [Q9BVG3-1] ENST00000543586.1 [Q9BVG3-2] Q9BVG3 |